Hospital Pharmacy - October 2019 - 334

334
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. Skidgel RA. Histamine, bradykinin, and their antagonists. In:
Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Goodman
& Gilman's: The Pharmacological Basis of Therapeutics. 13th
ed. New York, NY: McGraw-Hill; 2018.
2. Drugs@FDA: FDA Approved Drug Products. U.S. Food
and Drug Administration. https://www.accessdata.fda.gov
/scripts/cder/daf/index.cfm. Published May 29, 2018. Accessed
September 6, 2018.
3. Diphenhydramine Monographs. In: Lexi-Drugs. http://online
.lexi.com. Published May 29, 2018. Accessed September 6, 2018.
4. Campbell RL, Li JT, Nicklas RA, et al. Emergency department
diagnosis and treatment of anaphylaxis: a practice parameter.
Ann Allergy Asthma Immunol. 2014;113:599-608.
5. Rosello S, Blasco I, Garcia Fabregat L, Cervantes A, Jordan K;
ESMO Guidelines Committee. Management of infusion reactions to systemic anticancer therapy: ESMO clinical practice
guidelines. Ann of Oncol. 2017;28(suppl 4):iv100-iv118.
6. ISMP Safe Practice Guidelines for Adult IV Push Medications. Institute for Safe Medication Practices. https://
www.ismp.org/sites/default/files/attachments/2017-11/
ISMP97-Guidelines-071415-3.%20FINAL.pdf. Published
2015. Accessed September 6, 2018.

Hospital Pharmacy 54(5)
7. Diphenhydramine product package inserts. DailyMed. https:
//dailymed.nlm.nih.gov/dailymed/. Published May 25, 2018.
Accessed September 6, 2018.
8. Kirkland WD, Jones RW, Ellis JR, et al. Compatibility
studies of parenteral admixtures. Am J Hosp Pharm. 1961;
18:694-699.
9. Donnelly RF. Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes. Can J Hosp
Pharm. 1999;52:150-155.
10. Reynolds DW, Facchine KL, Mullaney JF, et al. Available
guidance and best practices for conducting forced degradation
studies. Pharm Technol. 2002; 26: 48-54.
11. Bliesner DM. Components of methods validation. In:
Validating Chromatographic Methods. Hoboken, NJ: John
Wiley & Sons, Inc; 2006.
12. Diphenhydramine product monographs. In: USP 41-NF 36.
The United States Pharmacopeial Convention. www.usp.org.
Published May 25, 2018. Accessed September 6, 2018.
13. General chapter 797: pharmaceutical compounding-sterile preparations. In: USP 41-NF 36. The United States
Pharmacopeial Convention. www.usp.org. Published May 25,
2018. Accessed September 6, 2018.
14. Trissel LA. Diphenhydramine hydrochloride monograph.
In: Trissel's Stability of Compounded Formulations. 5th
ed. Washington, DC: American Pharmacists Association;
2012:172.
15. Sodium chloride injection monograph. In: USP 41-NF 36.
The United States Pharmacopeial Convention. www.usp.org.
Published May 25, 2018. Accessed September 6, 2018.
16. Dextrose injection monograph. In: USP 41-NF 36. The United
States Pharmacopeial Convention. www.usp.org. Published
May 25, 2018. Accessed September 6, 2018.

https://www.accessdata.fda.gov/scripts/cder/daf/ https://www.accessdata.fda.gov/scripts/cder/daf/ http://www.usp.org http://online.lexi.com https://online.lexi.com/lco/action/login http://www.usp.org http://www.usp.org https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP97-Guidelines-071415-3.%20FINAL.pdf https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP97-Guidelines-071415-3.%20FINAL.pdf https://www.ismp.org/sites/default/files/attachments/2017-11/ISMP97-Guidelines-071415-3.%20FINAL.pdf http://www.usp.org

Hospital Pharmacy - October 2019

Table of Contents for the Digital Edition of Hospital Pharmacy - October 2019